Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHKA known ✓ | P35790 | 8/20 | 0.36 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | XDH | P47989 | 1/20 | 0.32 |
| ▸ | KDM4A | O75164 | 1/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23301461 | 0.98 | ALDH1A1 (0.38) | ALDH1A1CA1CA2CHKAHDAC8 | |
| Hydrochloric Acid SCHEMBL23301430 | 0.97 | CA1 (0.39) | ALDH1A1CA1CA2CHKAHDAC8 | |
| Iodide SCHEMBL30071069 | 0.97 | ALDH1A1 (0.37) | ALDH1A1CA1CA2CHKAHDAC8 | |
| Sulfuric Acid SCHEMBL30240036 | 0.91 | TDP1 (0.38) | ALDH1A1CA1CA2CHKAHDAC8 | |
| Sulfuric Acid SCHEMBL30071055 | 0.90 | TDP1 (0.44) | ALDH1A1CA1CA2 | |
| Acetic Acid SCHEMBL23301130 | 0.87 | CA1 (0.34) | CA1CA2HDAC8 | |
| SCHEMBL30578239 | 0.87 | TDP1 (0.38) | CA1CA2 | |
| Benzylimidazole SCHEMBL30578260 | 0.81 | CA1 (0.36) | ALDH1A1CA1CA2CHKAACHE | |
| SCHEMBL31598838 | 0.78 | ALDH1A1 (0.50) | ALDH1A1CA1CA2CHKAHDAC8 | |
| Benzylimidazole SCHEMBL16237306 | 0.77 | CHKA (0.46) | ALDH1A1CHKAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3166981-B1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12514267-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2026-01-06 | — | — | US | disclosed |
| US-12410206-B2 | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250057202-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2025-02-20 | — | — | US | disclosed |
| EP-3459975-B1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2024-10-02 | — | — | EP | disclosed |
| CN-113056488-B | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | DSM营养产品有限责任公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. | 2023-08-17 | — | — | US | disclosed |
| US-11697692-B2 | Methods of producing glycan polymers | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-07-11 | — | — | US | disclosed |
| EP-4205553-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | DSM Nutritional Products, LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | DSM NUTRITIONAL PRODUCTS, LLC | 2022-12-29 | — | — | US | disclosed |
| US-20220400728-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-12-22 | — | — | US | disclosed |
| EP-3636077-B1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-11-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | FUT5, FUT6, OSTC | CHKA 3195/4885ACHE 3795/4885ALDH1A1 3518/4885 |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | OSTC, FUT5, FUT6 | CHKA 2978/4885ACHE 2740/4885ALDH1A1 2641/4885 |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | FUT5, FUT6, OSTC | CHKA 3195/4885ACHE 3795/4885ALDH1A1 3518/4885 |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | FUT6, FUT5, PIGS | CHKA 3488/4885ACHE 2759/4885ALDH1A1 2993/4885 |
| US-12410206-B2 | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | OAT, OTC, FUCA2 | CHKA 1113/4885ACHE 1847/4885ALDH1A1 1582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.